About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00550602

Tracheobronchomalacia: Treatment Outcomes

The purpose of this study is to evaluate respiratory symptoms and their impact in the quality of life and after treatment of the respiratory condition (tracheobronchomalacia - TBM).

Lead sponsor: Beth Israel Deaconess Medical Center•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Beth Israel Deaconess Medical Center

TBM is an abnormal collapse of the tracheal and bronchial walls. It is characterized by flaccidity of the supporting tracheal and bronchial structures and a significant reduction of airway diameter on expiration seen in the trachea and/or in the mainstem bronchi. Currently there is no available data on the efficacy of central airway stabilization for treating TBM. Our study would provide this important information and would establish the effect of central airway stabilization on symptoms, functional status, quality of life, lung function and exercise capacity in patients with symptomatic and severe TBM.

Age

21 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Suspicion of symptomatic tracheal and/or bronchial collapse during bronchoscopy or Dynamic Computed Tomographic study.
•Chronic Obstructive Pulmonary Disease (regardless of severity) and suspicion of tracheal and/or bronchial collapse

Exclusion Criteria

•inability to follow commands
•Focal extrinsic compression of the trachea/bronchi by mass or other

Related studies

Bioresorbable Airway Splint Pivotal Clinical Trial

NCT06406452 · Tracheobronchomalacia

Enrolling By InvitationNA

Feasibility of Tracheobronchial Reconstruction Using Allogenic Aortic Patch in Children

NCT07240259 · Trachea Diseases, Tracheal Stenosis, and more

Enrolling By InvitationNA

Primary Posterior Tracheopexy Prevents Tracheal Collapse

NCT06335862 · Oesophageal Atresia With Tracheo-Oesophageal Fistula, Tracheomalacia, and more

Not Yet RecruitingPhase 3

Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention

NCT06409299 · Tracheomalacia, Bronchopulmonary Dysplasia (BPD), and more

Portable Continuous Positive Airways Pressure (CPAP) in Excessive Central Airway Collapse (ECAC) Study

NCT06072872 · Excessive Central Airways Collapse, Respiratory Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 3, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment150

Start dateJan 2002

Last updatedFeb 3, 2017

Condition

Tracheomalacia Tracheobronchomalacia

Locations shown

Beth Israel Deaconess Medical Center- Division of Interventional Pulmonology

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 3, 2017Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions